General
Preferred name
CAFFEIC ACID
Synonyms
3,4-Dihydroxycinnamic Acid ()
trans-Caffeic acid ()
trans-Caffeate ()
2-PROPENOIC ACID, 3-(3,4-DIHYDROXYPHENYL)-, (2E)- ()
Trans-3,4-dihydroxycinnamic acid ()
NSC-623438 ()
NSC-57197 ()
Cinnamic acid, 3,4-dihydroxy- ()
Caffeic Acid-13C3 ()
P&D ID
PD000777
CAS
331-39-5
71693-97-5
501-16-6
1185245-82-2
Tags
available
natural product
drug candidate
Drug indication
autoimmune thrombocytopenic purpura
Thrombocytopenia
Drug Status
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Caffeic acid is an inhibitor of both TRPV1 ion channel and 5-Lipoxygenase (5-LO).
DESCRIPTION
Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative with anti-oxidant, anti-inflammatory, and antineoplastic activities. It inhibts 5-Lipoxygenase with IC50= 3µM.
(Enamine Bioactive Compounds)
DESCRIPTION
Antioxidant; inhibits the synthesis of leukotrienes that are involved in immunoregulation and inflammation
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
8
Organisms
6
Compound Sets
19
AdooQ Bioactive Compound Library
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
Novartis Chemogenetic Library (NIBR MoA Box)
Nuisance compounds in cellular assays
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
142
Molecular Weight
180.04
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.2
TPSA
77.76
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.47
Structural alerts
1
Nonspecific/NOS
IMP
Nuisance compounds
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Lipoxygenase
TRP Channel
ALOX5, MIF
Lipoxygenase,TRP Channel
Selectivity
Antioxidant
MOA
TRP/TRPV Channel
5-Lipoxygenase Inhibitors
HIV Integrase Inhibitors
Antioxidants
HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor
Member status
member
Pathway
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
Source data

